维生素D结合蛋白基因变异影响婴儿维生素D状态及补充反应
该随机对照试验纳入913名健康足月婴儿,从2周至24个月补充维生素D3(10或30 μg/d),发现GC基因多个SNP及单倍型与25OHD浓度较低相关,且在高剂量组中基因型显著影响补充反应。
要点
- GC基因SNP次等位基因纯合子与婴儿各时间点25OHD浓度较低相关。
- 30 μg/d组中GC基因型显著影响25OHD对补充的反应,10 μg/d组无此影响。
- 次等位基因纯合子补充后25OHD升高幅度更小。
核心结论
- 婴儿中维生素D结合蛋白基因型影响25OHD浓度及高剂量维生素D3补充的效率。
研究设计与样本
- 随机对照试验,913名健康足月婴儿从2周至24个月补充维生素D3 10或30 μg/d。
- 对GC基因SNP rs2282679、rs4588、rs7041、rs1155563进行基因分型并分析单倍型。
主要发现
- 所有研究SNP的次等位基因纯合子、组合单倍型及rs4588/rs7041二倍型2/2与一个或两个干预组所有时间点25OHD浓度较低相关(ANCOVA P < 0.043),但rs7041不影响出生时25OHD。
- 30 μg/d组中rs2282679、rs4588、rs7041基因型、二倍型及Haplo3SNP显著影响干预反应(重复测量ANCOVA Pinteraction < 0.019),10 μg/d组无此影响。
- 次等位基因纯合子在整个干预期间25OHD浓度较低且升高幅度较小。
临床怎么用
- 婴儿维生素D补充效果可能受GC基因型影响,高剂量补充时基因型差异更明显。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Single nucleotide polymorphisms (SNPs) of the vitamin D binding protein encoding the GC (group component) gene affect 25-hydroxyvitamin D (25OHD) concentrations, but their influence on vitamin D status and response to vitamin D supplementation in infants is unknown. OBJECTIVE: To study GC genotype-related differences in 25OHD concentrations and the response to supplementation during a vitamin D intervention study in infants. DESIGN: In this randomized controlled trial, healthy term infants received vitamin D3 (10 or 30 μg/d) from 2 weeks to 24 months of age. GC SNPs rs2282679, rs4588, rs7041, and rs1155563 were genotyped. rs4588/7041 diplotype and haplotypes of rs2282679, rs4588, and rs7041 (Haplo3SNP) and of all four SNPs (Haplo4SNP) were determined. MAIN OUTCOME MEASURES: 25OHD measured in cord blood at birth and at 12 and 24 months during intervention. RESULTS: A total of 913 infants were included. Minor allele homozygosity of all studied GC SNPs, their combined haplotypes, and rs4588/rs7041 diplotype 2/2 were associated with lower 25OHD concentrations at all time points in one or both intervention groups [analysis of covariance (ANCOVA) P < 0.043], with the exception of rs7041, which did not affect 25OHD at birth. In the high-dose supplementation group receiving 30 μg/d vitamin D3, but not in those receiving 10 µg/d, genotype of rs2282679, rs4588, and rs7041; diplotype; and Haplo3SNP significantly affected intervention response (repeated measurement ANCOVA Pinteraction < 0.019). Minor allele homozygotes had lower 25OHD concentrations and smaller increases in 25OHD throughout the intervention. CONCLUSIONS: In infants, vitamin D binding protein genotype affects 25OHD concentration and efficiency of high-dose vitamin D3 supplementation.
引用
- Enlund-Cerullo M, Koljonen L, Holmlund-Suila E, et al. Genetic Variation of the Vitamin D Binding Protein Affects Vitamin D Status and Response to Supplementation in Infants. J Clin Endocrinol Metab. 2019. PMID: 31365099. doi:10.1210/jc.2019-00630
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。